IL6 and endothelial dysfunction: Additionally, an AngII-dependent increase in serum IL-6 concentration is also shown to induce downstream activation of STAT3 pathways and inhibit eNOS expression, leading to a decrease in NO and the promotion of endothelial dysfunction [82].